MDedge Crosswords

Psoriatic Arthritis Overview

Publish date: October 1, 2019

 

Recommended Reading

Secukinumab reduced joint pain of psoriatic arthritis in early data from phase 3b trial
MDedge Rheumatology
Hadlima approved as fourth adalimumab biosimilar in U.S.
MDedge Rheumatology
FDA finds increased blood clot, death risk associated with Xeljanz
MDedge Rheumatology
Psoriasis patients on biologics show improved heart health
MDedge Rheumatology
PROMIS tools provide useful data for managing rheumatology patients
MDedge Rheumatology
EULAR updates vaccination recommendations for autoimmune inflammatory rheumatic disease patients
MDedge Rheumatology
Cannabidiol may interact with rheumatologic drugs
MDedge Rheumatology
Long-term advantages may not endure after early tight control in psoriatic arthritis
MDedge Rheumatology
Obesity, moderate drinking linked to psoriatic arthritis
MDedge Rheumatology
Prior authorizations for infusibles cause delays, toxicities
MDedge Rheumatology